VISX and Summit dissolve Pillar Point partnership amid legal battles
This article was originally published in Clinica
Executive Summary
The six-year old partnership to share patents in the laser eye surgery industry, which was claimed to have been instrumental in artificially raising prices in the US, is over. VISX and Summit Technology agreed last week to dissolve Pillar Point Partners, their vehicle formed in 1992 to license patents jointly and collect a $250 fee per eye for each procedure carried out in the US.